Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Akzo's pharmaceutical sales rise in first half:

This article was originally published in Clinica

Executive Summary

In the first half of 1995, pharma revenues grew 5% at Dutch chemicals, fibres and pharma group Akzo Nobel. Pharma sales, which include Organon Teknika's diagnostics, increased to Fl 1,908 million ($1,066 million). Akzo attributed the growth to volume increases at Organon and its veterinary business. First-half group sales declined 3% to Fl 10,991 million, while net income improved to Fl 789 million compared with Fl 569 million in the previous year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT092732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel